Product Wiki · Recalls · EU Safety Gate (RAPEX)

Wireless on-ear headphones — recall SR/02484/25

EU Safety Gate (RAPEX) · Sweden · 2025-07-11 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02484/25
Date of alert
2025-07-11
Country / jurisdiction
Sweden
Risk level
Serious risk
Risk type
Chemical, Environment
Product category
Electrical appliances and equipment
Product type
Headphones
Reported risk: The solders in the product have an excessive concentration of lead and cadmium (measured values up to 67.8 % and 0.054% by weight respectively). The plastic material of the cable has an excessive concentration of DEHP, DPB and DIBP (measured values up to 1.8%, 1.2% and 0.4% by weight respectively). The plastic also has an excessive concentration of short-chain chlorinated paraffins (SCCPs) (measured value up to 0.6 % by weight). Lead and cadmium pose a risk to the environment. DEHP, DPB and DIBP may harm the health by causing possible damage to the reproductive system. SCCPs persist in the environment, are toxic to aquatic organisms at low concentrations and bio-accumulate in wildlife and humans, posing a risk to human health and the environment. The product does not comply with the requirements of the Directive on the restriction of the use of certain hazardous substances in electrical and electronic equipment (RoHS 2 Directive) nor with the Persistent Organic Pollutants (POP) Regulation.
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10095088

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.